Mold-Tek Packaging Ltd Q4 FY26 Earnings Analysis
Published 18 Aug 2026 | Industrial Products | Market Cap: ₹2.3K Cr
Price
₹680
Market Cap
₹2.3K Cr
P/E Ratio
30.3
Earnings Summary
Volume growth for FY '27 is expected to be between 10% to 13%, primarily because Pharma volumes will remain low despite high value growth. Targeting at least INR 210 crores EBITDA in FY 2026-27, up from INR 173 crores, indicating ~20% growth.
📊 Revenue & Sales Performance
- →Volume growth for FY '27 is expected to be between 10% to 13%, primarily because Pharma volumes will remain low despite high value growth.
- →Value growth guidance for FY '27 is 13% to 15%, driven by higher realizations and client additions, especially in Food, FMCG, Paints, and ABG segments.
- →The Lubricant segment is expected to remain stagnant with no major volume growth.
- →Asian Paints and ABG are key growth drivers, with Asian Paints expected to improve from ~3.5% annual growth to around 10% in FY '27.
- →Food and FMCG, especially from the North (Panipat) plant, are anticipated to grow at around 20%.
- →EBITDA per kg is targeted to improve to 42.5 in FY '27 and 43-44 in FY '28 due to operational efficiencies.
- →Revenue is expected to cross INR 1,000 crores in FY '27, with a target to surpass INR 1,200 crores by FY '28.
📈 Profitability & Margins
- →Targeting at least INR 210 crores EBITDA in FY 2026-27, up from INR 173 crores, indicating ~20% growth.
- →Aiming for 13%-15% value growth and 10%-13% volume growth in FY 2026-27.
- →EBITDA per kg expected to improve to 42.5 in FY 2026-27 from 40.7 in FY 2025-26, with potential to reach 43-44 in FY 2027-28.
- →ROCE expected to rise from 12.4% to around 13.5%-14% in FY 2026-27, possibly reaching 15% by FY 2027-28.
- →Profitability gains driven by increased business, operational efficiencies, consolidation of plants, and capacity utilization growth (70%+ expected in FY 2026-27).
- →No major downside expected barring unforeseen events like war impact; prospects could be better than guided.
- →Revenue expected to cross INR 1,000 crores in FY 2026-27 and potentially INR 1,200 crores by FY 2027-28.
🏗️ Capital Expenditure Plans
- →Planned capital expenditure for FY '27 is around INR 80-85 crores, primarily funded through internal accruals; no significant additional debt expected.
- →Focus on brownfield expansions mainly at Mysore and Satara (Mahad plant supply).
- →Addition of 4 new thin wall machines at Panipat in July, doubling thin wall capacity, aiming to increase capacity utilization from 20-25% to 40-50% next year.
- →New land acquired near Sultanpur for a Pharma plant; construction expected to start soon after land possession, with commercial production targeted by the end of FY '27 (possibly January 2028).
- →Consolidation of Hyderabad plants from 5 to 2 units to improve efficiency and reduce overheads.
- →Continued investments to support growth in Pharma packaging and sustainable capacity utilization crossing 70% from next year onwards.
💰 Fundraising & Capital Structure
- →No additional debt is expected for capacity expansion in FY '27; internal accruals will fund capex.
- →Planned capital expenditure for FY '27 is around INR 80-85 crores, mostly funded from internal cash generation.
- →Cash generation this year is around INR 100 crores net after dividend, sufficient for planned capex and debt repayment.
- →Debt repayment will happen from cash accruals, and overall debt is not expected to increase.
- →No mention of new equity fundraising or share issuance in the provided transcript.
- →The company focuses on brownfield expansions with limited capital needs going forward.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Mold-Tek Packaging Ltd Q4 FY26 results?
Volume growth for FY '27 is expected to be between 10% to 13%, primarily because Pharma volumes will remain low despite high value growth. Targeting at least INR 210 crores EBITDA in FY 2026-27, up from INR 173 crores, indicating ~20% growth.
What is Mold-Tek Packaging Ltd share price analysis?
Mold-Tek Packaging Ltd currently shows a neutral. The stock trades at a P/E of 30.3 with a market cap of ₹2,307 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mold-Tek Packaging Ltd planning capital expenditure?
Planned capital expenditure for FY '27 is around INR 80-85 crores, primarily funded through internal accruals; no significant additional debt expected.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.